BioStratum
Executive Summary
Therapeutics for basal lamina-mediated diseases.
You may also be interested in...
Sandoz’ Saynor Insists On Value Of ‘Pure Play’ Approach
Sandoz is benefiting from its focus on a “pure play” generics and biosimilars model that is unique among its peers, CEO Richard Saynor tells Generics Bulletin in an exclusive interview.
Coronavirus Update: No Sign Of Agreement In EU's Bitter Row With AstraZeneca Over Vaccine Supplies
The dispute over a likely 60% reduction in supplies of AstraZeneca's COVID-19 vaccine shows no sign of resolution.
Cosmetic Talc Stakeholders Should Be Watching US EPA Asbestos Developments In 2021
In December, a California federal court ordered the US Environmental Protection Agency to amend its TSCA Chemical Data Reporting rule to address asbestos information-gathering “loopholes,” including a current exemption for asbestos that occurs as an impurity in raw materials such as cosmetic talc.
Need a specific report? 1000+ reports available
Buy Reports